Compounds > methylprednisolone

methylprednisolone and Leukemia, Myelomonocytic, Acute

methylprednisolone has been researched along with Leukemia, Myelomonocytic, Acute in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castaigne, S; Farhat, H; Garcia, I; Ghez, S; Merabet, F; Pilorge, S; Preudhomme, C; Rabian, F; Raggueneau, V; Renneville, A; Rigaudeau, S; Rousselot, P; Sarkozy, C; Taksin, AL; Terré, C1
Albayrak, D1
Czarnetzki, BM; Krüger-Krasagakes, S; Lippert, U; Möller, A; Nürnberg, W; Welker, P1
Cetin, M; Cotter, TG; Erdemli, E; Hiçsönmez, G; Ozbek, N; Tekelioglu, M; Tuncer, AM1
Kotsopoulou, M; Kyrtsoni, MC; Maniatis, A; Mouratidou, M; Papakonstantinou, C; Papanastasiou, K; Pouli, A; Sotiropoulos, D; Stamatelou, M1

Other Studies

5 other study(ies) available for methylprednisolone and Leukemia, Myelomonocytic, Acute

ArticleYear
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.
    American journal of hematology, 2014, Volume: 89, Issue:4

    Topics: Aged; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Compassionate Use Trials; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Filgrastim; Gemtuzumab; Granulocyte Colony-Stimulating Factor; Humans; Immunophenotyping; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Methylprednisolone; Middle Aged; Neutropenia; Nucleophosmin; Recombinant Proteins; Remission Induction; Salvage Therapy; Thrombocytopenia

2014
Pseudorelapse in acute myelomonocytic leukemia after high dose methylprednisolone.
    Leukemia research, 1994, Volume: 18, Issue:1

    Topics: Adolescent; Bone Marrow; Female; Humans; Leukemia, Myelomonocytic, Acute; Methylprednisolone; Neutropenia; Recurrence

1994
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells.
    International archives of allergy and immunology, 1996, Volume: 109, Issue:2

    Topics: Administration, Topical; Anti-Inflammatory Agents; Cytokines; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Leukocytes, Mononuclear; Lipopolysaccharides; Methylprednisolone; Tumor Cells, Cultured

1996
Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2

    Topics: Apoptosis; Bone Marrow; Cell Differentiation; Child; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Methylprednisolone; Microscopy, Electron; Neoplastic Stem Cells; Staining and Labeling

1996
Chemotherapy-related acute rhabdomyolysis.
    Journal of the National Cancer Institute, 1992, Apr-01, Volume: 84, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Humans; Leukemia, Myelomonocytic, Acute; Methylprednisolone; Middle Aged; Prednisolone; Rhabdomyolysis; Thioguanine; Vincristine

1992